Passage BIO, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
PASG on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Commerce Square, 2005 Market Street, 39 Th Floor, Philadelphia, PA

Insiders trading volume in the past year

Passage BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lynx1 Capital Management LP 10%+ Owner $8.17M Aug 7, 2024
Orbimed Advisors Llc 10%+ Owner $7.31M Jun 27, 2023
Jill M. Quigley Chief Operating Officer $339K Dec 8, 2021
Mark S. Forman Chief Medical Officer $56.3K -$16K -22.1% Mar 15, 2024
Alexandros Fotopoulos Chief Technical Officer $48.9K Jun 15, 2023
Edgar Cale Gc & Corporate Secretary $41.9K -$14.4K -25.6% Mar 15, 2024
Kathleen Borthwick Cfo $35.4K -$11.1K -23.9% Mar 15, 2024
Simona King Chief Financial Officer $21.8K Jul 28, 2023
Monika Maria Toernsen Chief Commercial Officer $16.7K Sep 15, 2022
Bruce A. Goldsmith CEO and President, Director $14.5K May 27, 2022
Richard Morris Chief Financial Officer $4.96K May 21, 2021
Michael E. Kamarck Director May 25, 2023
Thomas Woiwode Director, 10%+ Owner May 25, 2023
Brian Burkavage Controller May 30, 2021
Sandip Kapadia Director May 21, 2024
William Chou PRESIDENT AND CEO, Director Mar 15, 2024
Dolan Sondhi Director May 21, 2024
Maxine Gowen Director May 21, 2024
Athena Countouriotis Director May 21, 2024
Saqib Islam Director May 21, 2024
Derrell Porter Director May 21, 2024
Liam Ratcliffe Director May 27, 2021
Tadataka Yamada Director May 27, 2021
Eliseo Oreste Salinas Chief Res. & Develop Officer Feb 10, 2022

Recent Insider Transactions by Companies or Individuals for Passage BIO, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.